.

The next decade: therapies and brain health

26th March 2024

Francis Crick Institute London

In person

The decade ahead will be one of significant change in the dementia field. The first disease modifying treatments for dementia have been approved in some countries. The likelihood is the next decade will see treatments for more targets, at different stages of disease and using different mechanisms. Blood biomarkers will be increasingly used in specialist centres, firstly, and then more routinely in clinical practice. Potentially digital biomarkers will be increasingly important in detection. For sure, to benefit from treatments patients will need to be diagnosed much earlier in the disease trajectory than is the norm today, potentially identified through screening populations classified by age or other risk factors. The pace of change depends on what both science and health systems can deliver. But, as with other disease areas, cardiovascular and cancer being examples, effectively managing the impact disease has on a population involves effectively treating disease (therapeutics and timely diagnosis) and preventing disease. Research is evolving but the evidence is increasingly individuals (and public policy) can keep their brain health and reduces the risk of cognitive decline.

The summit will address:

• How to maintain brain health and prevent disease

• How to diagnose earlier and treat better contributing to keeping people as well as possible for as long as possible

The programme will be released this fall. For more information on participating email info@worlddementiacouncil.com